IFP Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

IFP Advisors’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-8	Closed	-$458	–	3151
2020 Q3	$0	Buy	+8	New	+$431	﹤0.01%	3059

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

IFP Advisors's CCXI Position: Q4 2020 in Review

IFP Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q4 2020, closing a stake of 8 shares — an estimated $458 sold.

IFP Advisors first reported a position in CCXI in Q3 2020 and held it in 1 quarter. The position peaked at $0 in Q3 2020. 196 funds tracked by Wall St. Rank hold CCXI as of Q4 2020.

IFP Advisors reported no remaining ChemoCentryx, Inc. position as of Q4 2020 after selling out during the quarter.
IFP Advisors sold 8 ChemoCentryx, Inc. shares in Q4 2020, an estimated $458.
IFP Advisors first reported a position in ChemoCentryx, Inc. in Q3 2020 and held it in 1 quarter.
IFP Advisors's ChemoCentryx, Inc. position peaked at $0 in Q3 2020.
196 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2020.

Based on IFP Advisors's 13F filing for Q4 2020, filed 25 Jan 2021.